Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Terrinoni

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Cancer Treatment and Research Communications|December 18, 2020
Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progressionMaria Cristina Rapanotti, Tara Mayte Suarez Viguria, Giulia Spallone, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 10, 2021
Serum iPTH range in a reference population: From an integrated approach to vitamin D prevalence impact evaluationMarilena Minieri, Bruno Daniele Leoni, Lorenza Bellincampi, et al.
Journal of Cell Science|June 10, 2011
Differential altered stability and transcriptional activity of ΔNp63 mutants in distinct ectodermal dysplasiasGareth Browne, Rita Cipollone, Anna Maria Lena, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 3, 2002
Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patientFrancesca Bernassola, Massimo Federici, Marco Corazzari, et al.
Molecular and Cellular Biology|December 2, 2004
PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73Eliana Munarriz, Daniela Barcaroli, Anastasis Stephanou, et al.
American Journal of Human Genetics|December 29, 2005
A homozygous missense mutation in TGM5 abolishes epidermal transglutaminase 5 activity and causes acral peeling skin syndromeAndrew J Cassidy, Maurice A M van Steensel, Peter M Steijlen, et al.
International Journal of Molecular Sciences|November 27, 2021
MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid BiopsyMaria Cristina Rapanotti, Elisa Cugini, Marzia Nuccetelli, et al.
Cell Cycle (Georgetown, Tex.)|April 12, 2013
p63 regulates glutaminase 2 expressionArianna Giacobbe, Lucilla Bongiorno-Borbone, Francesca Bernassola, et al.
Frontiers in Clinical Diabetes and Healthcare|April 8, 2026
Association between triglyceride-glucose (TyG) index and diabetic foot ulcers in adult inpatients with type 2 diabetes at hospital admissionAlessandro De Stefano, Donatella Pastore, Marco Infante, et al.
The Journal of Cell Biology|October 17, 2012
miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migrationIvano Amelio, Anna Maria Lena, Giuditta Viticchiè, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Cancer Treatment and Research Communications|December 18, 2020
Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progressionMaria Cristina Rapanotti, Tara Mayte Suarez Viguria, Giulia Spallone, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 10, 2021
Serum iPTH range in a reference population: From an integrated approach to vitamin D prevalence impact evaluationMarilena Minieri, Bruno Daniele Leoni, Lorenza Bellincampi, et al.
Journal of Cell Science|June 10, 2011
Differential altered stability and transcriptional activity of ΔNp63 mutants in distinct ectodermal dysplasiasGareth Browne, Rita Cipollone, Anna Maria Lena, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 3, 2002
Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patientFrancesca Bernassola, Massimo Federici, Marco Corazzari, et al.
Molecular and Cellular Biology|December 2, 2004
PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73Eliana Munarriz, Daniela Barcaroli, Anastasis Stephanou, et al.
American Journal of Human Genetics|December 29, 2005
A homozygous missense mutation in TGM5 abolishes epidermal transglutaminase 5 activity and causes acral peeling skin syndromeAndrew J Cassidy, Maurice A M van Steensel, Peter M Steijlen, et al.
International Journal of Molecular Sciences|November 27, 2021
MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid BiopsyMaria Cristina Rapanotti, Elisa Cugini, Marzia Nuccetelli, et al.
Cell Cycle (Georgetown, Tex.)|April 12, 2013
p63 regulates glutaminase 2 expressionArianna Giacobbe, Lucilla Bongiorno-Borbone, Francesca Bernassola, et al.
Frontiers in Clinical Diabetes and Healthcare|April 8, 2026
Association between triglyceride-glucose (TyG) index and diabetic foot ulcers in adult inpatients with type 2 diabetes at hospital admissionAlessandro De Stefano, Donatella Pastore, Marco Infante, et al.
The Journal of Cell Biology|October 17, 2012
miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migrationIvano Amelio, Anna Maria Lena, Giuditta Viticchiè, et al.
Pageof 8